{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:11:09Z","timestamp":1775023869900,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006112","name":"Microsoft Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006112","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11883-025-01326-7","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T06:28:15Z","timestamp":1754980095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Renal Denervation for Hypertension: Current Evidence and Clinical Perspectives"],"prefix":"10.1007","volume":"27","author":[{"given":"Jason","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joey","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Bockus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"1326_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"B Zhou","year":"2021","unstructured":"Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957\u201380.","journal-title":"Lancet"},{"key":"1326_CR2","doi-asserted-by":"crossref","unstructured":"Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL et al. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation; 2024;149.","DOI":"10.1161\/CIR.0000000000001247"},{"key":"1326_CR3","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1161\/HYPERTENSIONAHA.122.19222","volume":"79","author":"P Muntner","year":"2022","unstructured":"Muntner P, Miles MA, Jaeger BC, Hannon Iii L, Hardy ST, Ostchega Y, et al. Blood pressure control among US adults, 2009 to 2012 through 2017 to 2020. Hypertens Hypertens. 2022;79:1971\u201380.","journal-title":"Hypertens Hypertens"},{"key":"1326_CR4","doi-asserted-by":"publisher","unstructured":"Zhou D, Xi B, Zhao M, Wang L, Veeranki SP. Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: the NHANES III Linked Mortality Study. Scientific Reports [Internet]. Scientific Reports; 2018;8. Available from: https:\/\/doi.org\/10.1038\/s41598-018-27377-2","DOI":"10.1038\/s41598-018-27377-2"},{"key":"1326_CR5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.amepre.2010.02.016","volume":"38","author":"TA Farley","year":"2010","unstructured":"Farley TA, Dalal MA, Mostashari F, Frieden TR. Deaths preventable in the U.S. By improvements in use of clinical preventive services. American journal of preventive medicine. Am J Prev Med. 2010;38:600\u20139.","journal-title":"Am J Prev Med"},{"key":"1326_CR6","doi-asserted-by":"publisher","unstructured":"Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies [published correction appears in Lancet. 2003;361(9362):1060]. Lancet. 2002;360(9349):1903\u20131913. https:\/\/doi.org\/10.1016\/s0140-6736(02)11911-8","DOI":"10.1016\/s0140-6736(02)11911-8"},{"key":"1326_CR7","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","volume":"383","author":"E Rapsomaniki","year":"2014","unstructured":"Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1\u00b725 million people. Lancet. 2014;383:1899\u2013911.","journal-title":"Lancet"},{"key":"1326_CR8","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology\/American heart association task force on clinical Pr. Hypertension; 2018;71:e13\u201315.","DOI":"10.1161\/HYP.0000000000000065"},{"key":"1326_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/CIRCULATIONAHA.121.055177","volume":"146","author":"E Vidal-Petiot","year":"2022","unstructured":"Vidal-Petiot E. Thresholds for hypertension definition, treatment initiation, and treatment targets: recent guidelines at a glance. Circulation. 2022;146:805\u20137.","journal-title":"Circulation"},{"issue":"12","key":"1326_CR10","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, et al. 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European society of hypertension: endorsed by the international society of hypertension (ISH) and the European renal association (ERA). J Hypertens. 2023;41(12):1874\u20132071. https:\/\/doi.org\/10.1097\/HJH.0000000000003480.","journal-title":"J Hypertens"},{"key":"1326_CR11","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW Mcevoy","year":"2024","unstructured":"Mcevoy JW, Mccarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J Eur Heart J. 2024;45:3912\u20134018.","journal-title":"Eur Heart J Eur Heart J"},{"key":"1326_CR12","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertens Hypertens. 2020;75:1334\u201357.","journal-title":"Hypertens Hypertens"},{"issue":"2","key":"1326_CR13","doi-asserted-by":"publisher","first-page":"108389","DOI":"10.1016\/j.jdiacomp.2022.108389","volume":"37","author":"Y Handelsman","year":"2023","unstructured":"Handelsman Y, Butler J, Bakris GL, et al. Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases. J Diabetes Complications. 2023;37(2):108389. https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108389.","journal-title":"J Diabetes Complications"},{"key":"1326_CR14","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/jama.2022.19590","volume":"328","author":"RM Carey","year":"2022","unstructured":"Carey RM, Moran AE, Whelton PK. Treatment of hypertension. JAMA JAMA. 2022;328:1849.","journal-title":"JAMA JAMA"},{"key":"1326_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2147\/TCRM.S1458","volume":"4","author":"S-C Li","year":"2008","unstructured":"Li S-C. Factors affecting therapeutic compliance: A review from the patient\u2019s perspective. Therapeutics and clinical risk management. Ther Clin Risk Manag. 2008;4:269\u201386.","journal-title":"Ther Clin Risk Manag"},{"key":"1326_CR16","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1161\/HYPERTENSIONAHA.124.22753","volume":"81","author":"J-B De Freminville","year":"2024","unstructured":"De Freminville J-B, Gardini M, Cremer A, Camelli S, Baron S, Bobrie G, et al. Prevalence and risk factors for secondary hypertension in young adults. Hypertens Hypertens. 2024;81:2340\u20139.","journal-title":"Hypertens Hypertens"},{"issue":"7","key":"1326_CR17","first-page":"453","volume":"96","author":"L Charles","year":"2017","unstructured":"Charles L, Triscott J, Dobbs B. Secondary hypertension: discovering the underlying cause. Am Fam Physician. 2017;96(7):453\u201361.","journal-title":"Am Fam Physician"},{"issue":"3","key":"1326_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/ajh\/hpu151","volume":"28","author":"D Achelrod","year":"2015","unstructured":"Achelrod D, Wenzel U, Frey S. Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations. Am J Hypertens. 2015;28(3):355\u201361. https:\/\/doi.org\/10.1093\/ajh\/hpu151.","journal-title":"Am J Hypertens"},{"key":"1326_CR19","doi-asserted-by":"crossref","unstructured":"Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, Egan BM, Flack JM, Gidding SS, Judd E, Lackland DT, Laffer CL, Newton-Cheh C, Smith SM, Taler SJ, Textor SC, Turan TN, White WB. Resistant hypertension: detection, evaluation, and management: A scientific statement from the American heart association. Hypertension. 2018;72.","DOI":"10.1161\/HYP.0000000000000084"},{"key":"1326_CR20","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/S0140-6736(22)02034-7","volume":"400","author":"MP Schlaich","year":"2022","unstructured":"Schlaich MP, Bellet M, Weber MA, Danaietash P, Bakris GL, Flack JM, et al. Dual endothelin antagonist Aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial. Lancet. 2022;400:1927\u201337.","journal-title":"Lancet"},{"key":"1326_CR21","doi-asserted-by":"crossref","unstructured":"Marzano L, Merlo M, Martinelli N, Pizzolo F, Friso S. Efficacy and Safety of Aldosterone Synthase Inhibitors for Hypertension: A Meta-Analysis of Randomized Controlled Trials and Systematic Review. Hypertension; 2025;82.","DOI":"10.1161\/HYPERTENSIONAHA.124.23962"},{"key":"1326_CR22","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1161\/HYPERTENSIONAHA.121.17570","volume":"78","author":"R Aggarwal","year":"2021","unstructured":"Aggarwal R, Chiu N, Wadhera RK, Moran AE, Raber I, Shen C, et al. Racial\/Ethnic disparities in hypertension prevalence, awareness, treatment, and control in the united states, 2013 to 2018. Hypertension. 2021;78:1719\u201326.","journal-title":"Hypertension"},{"issue":"2","key":"1326_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/HPC.0b013e318053da59","volume":"6","author":"KC Ferdinand","year":"2007","unstructured":"Ferdinand KC, Armani AM. The management of hypertension in African Americans. Crit Pathw Cardiol. 2007;6(2):67\u201371. https:\/\/doi.org\/10.1097\/HPC.0b013e318053da59.","journal-title":"Crit Pathw Cardiol"},{"issue":"9","key":"1326_CR24","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1097\/01.asn.0000026493.18542.6]","volume":"13","author":"ME Tarver-Carr","year":"2002","unstructured":"Tarver-Carr ME, Powe NR, Eberhardt MS, et al. Excess risk of chronic kidney disease among African-American versus white subjects in the united states: a population-based study of potential explanatory factors. J Am Soc Nephrol. 2002;13(9):2363\u201370. https:\/\/doi.org\/10.1097\/01.asn.0000026493.18542.6].","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"1326_CR25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jacc.2012.04.026","volume":"60","author":"F Guo","year":"2012","unstructured":"Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among united States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60(7):599\u2013606. https:\/\/doi.org\/10.1016\/j.jacc.2012.04.026.","journal-title":"J Am Coll Cardiol"},{"key":"1326_CR26","unstructured":"Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the united states: National health and nutrition examination survey, 2011\u20132012. NCHS Data Brief. 2013;(133):1\u20138."},{"key":"1326_CR27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1161\/01.HYP.0000182659.03194.db","volume":"46","author":"DM Lloyd-Jones","year":"2005","unstructured":"Lloyd-Jones DM, Sutton-Tyrrell K, Patel AS, Matthews KA, Pasternak RC, Everson-Rose SA, et al. Ethnic variation in hypertension among premenopausal and perimenopausal women. Hypertens Hypertens. 2005;46:689\u201395.","journal-title":"Hypertens Hypertens"},{"key":"1326_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11886-022-01826-x","volume":"25","author":"AA Abrahamowicz","year":"2023","unstructured":"Abrahamowicz AA, Ebinger J, Whelton SP, Commodore-Mensah Y, Yang E. Racial and ethnic disparities in hypertension: barriers and opportunities to improve blood pressure control. Curr Cardiol Rep. 2023;25:17\u201327.","journal-title":"Curr Cardiol Rep"},{"key":"1326_CR29","doi-asserted-by":"publisher","first-page":"e004313","DOI":"10.1161\/JAHA.116.004313","volume":"5","author":"J Fang","year":"2016","unstructured":"Fang J, Zhao G, Wang G, Ayala C, Loustalot F. Insurance status among adults with Hypertension\u2014The impact of underinsurance. J Am Heart Association. 2016;5:e004313.","journal-title":"J Am Heart Association"},{"issue":"4","key":"1326_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s13668-021-00364-2","volume":"10","author":"J Te Vazquez","year":"2021","unstructured":"Te Vazquez J, Feng SN, Orr CJ, Berkowitz SA. Food insecurity and cardiometabolic conditions: a review of recent research. Curr Nutr Rep. 2021;10(4):243\u201354. https:\/\/doi.org\/10.1007\/s13668-021-00364-2.","journal-title":"Curr Nutr Rep"},{"issue":"1","key":"1326_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/19320248.2018.1538921","volume":"15","author":"M Helmick","year":"2020","unstructured":"Helmick M, Smith,Teresa M, Parks, Courtney A, Hill JL. Food insecurity increases odds of diabetes and hypertension, not obesity in medically underserved region. J Hunger Environ Nutr. 2020;15(1):128\u201339. https:\/\/doi.org\/10.1080\/19320248.2018.1538921.","journal-title":"J Hunger Environ Nutr"},{"issue":"14","key":"1326_CR32","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1056\/NEJMoa1717250","volume":"378","author":"RG Victor","year":"2018","unstructured":"Victor RG, Lynch K, Li N, et al. A Cluster-Randomized trial of Blood-Pressure reduction in black barbershops. N Engl J Med. 2018;378(14):1291\u2013301. https:\/\/doi.org\/10.1056\/NEJMoa1717250.","journal-title":"N Engl J Med"},{"issue":"1","key":"1326_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/CIRCULATIONAHA.118.038165","volume":"139","author":"RG Victor","year":"2019","unstructured":"Victor RG, Blyler CA, Li N, et al. Sustainability of blood pressure reduction in black barbershops. Circulation. 2019;139(1):10\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038165.","journal-title":"Circulation"},{"key":"1326_CR34","doi-asserted-by":"publisher","first-page":"E106","DOI":"10.5888\/pcd16.180618","volume":"16","author":"SS Yi","year":"2019","unstructured":"Yi SS, Wyatt LC, Patel S, et al. A Faith-Based intervention to reduce blood pressure in underserved metropolitan new York immigrant communities. Prev Chronic Dis. 2019;16:E106. https:\/\/doi.org\/10.5888\/pcd16.180618.","journal-title":"Prev Chronic Dis"},{"key":"1326_CR35","doi-asserted-by":"publisher","first-page":"e0281940","DOI":"10.1371\/journal.pone.0281940","volume":"18","author":"L Reopell","year":"2023","unstructured":"Reopell L, Nolan TS, Gray DM, Williams A, Brewer LC, Bryant AL, et al. Community engagement and clinical trial diversity: navigating barriers and co-designing solutions\u2014A report from the health equity through diversity seminar series. PLoS ONE. 2023;18:e0281940.","journal-title":"PLoS ONE"},{"key":"1326_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/cts.2023.597","volume":"7","author":"DF Hanley","year":"2023","unstructured":"Hanley DF, Bernard GR, Wilkins CH, Selker HP, Dwyer JP, Dean JM, et al. Decentralized clinical trials in the trial innovation network: value, strategies, and lessons learned. J Clin Translational Sci. 2023;7:1\u201324.","journal-title":"J Clin Translational Sci"},{"key":"1326_CR37","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1038\/s41440-024-01677-9","volume":"47","author":"K Katsurada","year":"2024","unstructured":"Katsurada K, Patel KP. The role of afferent renal nerves in regulating sympathetic outflow via central nervous system mechanisms. Hypertens Res. 2024;47:1978\u201380.","journal-title":"Hypertens Res"},{"key":"1326_CR38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1001\/jama.1942.02830070007003","volume":"118","author":"G De Takats","year":"1942","unstructured":"De Takats G. THE SURGICAL APPROACH TO HYPERTENSION. JAMA. 1942;118:501.","journal-title":"JAMA"},{"key":"1326_CR39","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.110.163014","volume":"57","author":"Catheter-Based Renal","year":"2011","unstructured":"Catheter-Based Renal. Sympathetic denervation for resistant hypertension. Hypertension. 2011;57:911\u20137.","journal-title":"Hypertension"},{"issue":"9671","key":"1326_CR40","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","volume":"373","author":"H Krum","year":"2009","unstructured":"Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373(9671):1275\u201381. https:\/\/doi.org\/10.1016\/S0140-6736(09)60566-3.","journal-title":"Lancet"},{"issue":"9756","key":"1326_CR41","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","volume":"376","author":"HTN-2 Symplicity","year":"2010","unstructured":"Symplicity HTN-2, Investigators, Esler MD, Krum H, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376(9756):1903\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(10)62039-9.","journal-title":"Lancet"},{"key":"1326_CR42","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","volume":"370","author":"DL Bhatt","year":"2014","unstructured":"Bhatt DL, Kandzari DE, O\u2019Neill WW, D\u2019Agostino R, Flack JM, Katzen BT, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393\u2013401.","journal-title":"N Engl J Med"},{"key":"1326_CR43","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1161\/HYPERTENSIONAHA.115.05283","volume":"65","author":"S Desch","year":"2015","unstructured":"Desch S, Okon T, Heinemann D, Kulle K, R\u00f6hnert K, Sonnabend M, et al. Randomized Sham-Controlled trial of renal sympathetic denervation in mild resistant hypertension. Hypertens Hypertens. 2015;65:1202\u20138.","journal-title":"Hypertens Hypertens"},{"key":"1326_CR44","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1097\/HJH.0000000000000977","volume":"34","author":"ON Mathiassen","year":"2016","unstructured":"Mathiassen ON, Vase H, Bech JN, Christensen KL, Buus NH, Schroeder AP, et al. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial. J Hypertens. 2016;34:1639\u201347.","journal-title":"J Hypertens"},{"key":"1326_CR45","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/S0140-6736(17)32281-X","volume":"390","author":"RR Townsend","year":"2017","unstructured":"Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390:2160\u201370.","journal-title":"Lancet"},{"issue":"10234","key":"1326_CR46","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","volume":"395","author":"M B\u00f6hm","year":"2020","unstructured":"B\u00f6hm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020;395(10234):1444\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(20)30554-7.","journal-title":"Lancet"},{"issue":"10137","key":"1326_CR47","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/S0140-6736(18)30951-6","volume":"391","author":"DE Kandzari","year":"2018","unstructured":"Kandzari DE, B\u00f6hm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet. 2018;391(10137):2346\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(18)30951-6.","journal-title":"Lancet"},{"key":"1326_CR48","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.jacc.2023.08.045","volume":"82","author":"DE Kandzari","year":"2023","unstructured":"Kandzari DE, Townsend RR, Kario K, Mahfoud F, Weber MA, Schmieder RE, et al. Safety and efficacy of renal denervation in patients taking antihypertensive medications. Journal of the American college of cardiology. J Am Coll Cardiol. 2023;82:1809\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"1326_CR49","doi-asserted-by":"publisher","unstructured":"Thorp AA, Schlaich MP. Device-based approaches for renal nerve ablation for hypertension and beyond. Front Physiol [Internet] Front Physiol. 2015;6. https:\/\/doi.org\/10.3389\/fphys.2015.00193.","DOI":"10.3389\/fphys.2015.00193"},{"issue":"3","key":"1326_CR50","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/HJH.0000000000001584","volume":"36","author":"RE Schmieder","year":"2018","unstructured":"Schmieder RE, Ott C, Toennes SW, et al. Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IV. J Hypertens. 2018;36(3):680\u20139. https:\/\/doi.org\/10.1097\/HJH.0000000000001584.","journal-title":"J Hypertens"},{"key":"1326_CR51","doi-asserted-by":"publisher","unstructured":"Azizi M, Schmieder RE, Mahfoud F et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial [published correction appears in Lancet. 2018;392(10150):820. doi: 10.1016\/S0140-6736(18)32058-0.]. Lancet. 2018;391(10137):2335\u20132345. https:\/\/doi.org\/10.1016\/S0140-6736(18)31082-1","DOI":"10.1016\/S0140-6736(18)31082-1"},{"issue":"10293","key":"1326_CR52","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/S0140-6736(21)00788-1","volume":"397","author":"M Azizi","year":"2021","unstructured":"Azizi M, Sanghvi K, Saxena M, et al. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Lancet. 2021;397(10293):2476\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(21)00788-1.","journal-title":"Lancet"},{"key":"1326_CR53","doi-asserted-by":"publisher","unstructured":"Azizi M, Saxena M, Wang Y et al. Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial [published correction appears in JAMA. 2023;329(22):1989. doi: 10.1001\/jama.2023.8136.]. JAMA. 2023;329(8):651\u2013661. https:\/\/doi.org\/10.1001\/jama.2023.0713","DOI":"10.1001\/jama.2023.0713"},{"key":"1326_CR54","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1161\/CIRCULATIONAHA.124.069291","volume":"149","author":"DE Kandzari","year":"2024","unstructured":"Kandzari DE, Weber MA, Pathak A, Zidar JP, Saxena M, David SW, et al. Effect of Alcohol-Mediated renal denervation on blood pressure in the presence of antihypertensive medications: primary results from the TARGET BP I randomized clinical trial. Circulation. 2024;149:1875\u201384.","journal-title":"Circulation"},{"issue":"7","key":"1326_CR55","doi-asserted-by":"publisher","first-page":"602","DOI":"10.4244\/EIJ-D-23-00088","volume":"19","author":"A Pathak","year":"2023","unstructured":"Pathak A, Rudolph UM, Saxena M, et al. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications. EuroIntervention. 2023;19(7):602\u201311. https:\/\/doi.org\/10.4244\/EIJ-D-23-00088.","journal-title":"EuroIntervention"},{"issue":"10","key":"1326_CR56","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1038\/s41440-024-01739-y","volume":"47","author":"Y Ogoyama","year":"2024","unstructured":"Ogoyama Y, Abe M, Okamura K, et al. Effects of renal denervation on blood pressure in patients with hypertension: a latest systematic review and meta-analysis of randomized sham-controlled trials. Hypertens Res. 2024;47(10):2745\u201359. https:\/\/doi.org\/10.1038\/s41440-024-01739-y.","journal-title":"Hypertens Res"},{"key":"1326_CR57","doi-asserted-by":"crossref","unstructured":"Sesa-Ashton G, Nolde JM, Muente I, Carnagarin R, Macefield VG, Dawood T, Lambert EA, Lambert GW, Walton A, Esler MD, Schlaich MP. Long-Term blood pressure reductions following Catheter-Based renal denervation: A systematic review and Meta-Analysis. Hypertension. 2024;81.","DOI":"10.1161\/HYPERTENSIONAHA.123.22314"},{"issue":"8","key":"1326_CR58","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ehjqcco\/qcae001","volume":"10","author":"ASP Sharp","year":"2024","unstructured":"Sharp ASP, Cao KN, Esler MD, et al. Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence. Eur Heart J Qual Care Clin Outcomes. 2024;10(8):698\u2013708. https:\/\/doi.org\/10.1093\/ehjqcco\/qcae001.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"14","key":"1326_CR59","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jacc.2012.07.029","volume":"60","author":"BP Geisler","year":"2012","unstructured":"Geisler BP, Egan BM, Cohen JT, et al. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. J Am Coll Cardiol. 2012;60(14):1271\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2012.07.029.","journal-title":"J Am Coll Cardiol"},{"key":"1326_CR60","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1161\/CIRCULATIONAHA.123.067983","volume":"149","author":"W Vongpatanasin","year":"2024","unstructured":"Vongpatanasin W, Addo T. The next chapter of renal denervation after US food and drug administration approval. Circulation. 2024;149:760\u20133.","journal-title":"Circulation"},{"issue":"10","key":"1326_CR61","doi-asserted-by":"publisher","first-page":"101230","DOI":"10.1016\/j.jacadv.2024.101230","volume":"3","author":"PL Vemu","year":"2024","unstructured":"Vemu PL, Yang E, Ebinger JE. Moving toward a consensus: comparison of the 2023 ESH and 2017 ACC\/AHA hypertension guidelines. JACC Adv. 2024;3(10):101230. https:\/\/doi.org\/10.1016\/j.jacadv.2024.101230. Published 2024 Aug 28.","journal-title":"JACC Adv"},{"key":"1326_CR62","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ahj.2023.12.005","volume":"269","author":"KR Chitturi","year":"2024","unstructured":"Chitturi KR, Haberman D, Wermers JP, Waksman R. Overview of the 2023 FDA circulatory system devices advisory panel meeting on the symplicity Spyral renal denervation system. Am Heart J. 2024;269:108\u201317. https:\/\/doi.org\/10.1016\/j.ahj.2023.12.005.","journal-title":"Am Heart J"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-025-01326-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-025-01326-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-025-01326-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:20:46Z","timestamp":1757377246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-025-01326-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1326"],"URL":"https:\/\/doi.org\/10.1007\/s11883-025-01326-7","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"1 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies with human or animal subjects are published and followed ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"EY receives research funding from Microsoft Research. EY is a consultant for Idorsia and SkyLabs. EY receives honoraria from the American College of Cardiology. Other authors do not have any conflicts of interest or disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"79"}}